Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
8,179
+79
+1% +$15.7K 0.33% 51
2026
Q1
$1.19M Sell
8,100
-1,480
-15% -$217K 0.18% 65
2025
Q4
$1.16M Sell
9,580
-290
-3% -$34K 0.17% 67
2025
Q3
$1.06M Buy
9,870
+130
+1% +$12.1K 0.15% 72
2025
Q2
$872K Buy
9,740
+6,740
+225% +$507K 0.14% 78
2025
Q1
$204K Buy
+3,000
New +$216K 0.03% 203
2024
Q4
Sell
-2,850
Closed -$221K 230
2024
Q3
$221K Buy
2,850
+110
+4% +$8.63K 0.04% 191
2024
Q2
$226K Buy
+2,740
New +$202K 0.04% 176

Other funds holding KLAC

CFO4Life Group's KLAC Position: Q2 2026 in Review

CFO4Life Group increased its KLA (KLAC) stake by 0.98% in Q2 2026, buying an estimated $15.7K and bringing the position to 8,179 shares worth $2.47M. The position accounts for 0.33% of the portfolio, ranked #51.

CFO4Life Group first reported a position in KLAC in Q2 2024 and has held it in 8 quarters since. 2,485 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • CFO4Life Group held 8,179 shares of KLA worth $2.47M as of Q2 2026.
  • CFO4Life Group bought 79 KLA shares in Q2 2026, an estimated $15.7K.
  • KLA made up 0.33% of CFO4Life Group's portfolio in Q2 2026, its #51 holding.
  • CFO4Life Group first reported a position in KLA in Q2 2024 and has held it in 8 quarters since.
  • 2,485 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.